Victory Capital Management Inc Axsome Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 4,960 shares of AXSM stock, worth $482,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,960

Previous 5,035 1.49%

Holding current value

$482,955

Previous $405,000 9.88%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$78.93 - $95.84 $5,919 - $7,188	-75 Reduced 1.49%	4,960 $445,000
Q2 2024 Aug 05, 2024	SELL	$65.72 - $80.5 $4,666 - $5,715	-71 Reduced 1.39%	5,035 $405,000
Q1 2024 May 03, 2024	SELL	$69.39 - $97.64 $7,077 - $9,959	-102 Reduced 1.96%	5,106 $407,000
Q4 2023 Feb 05, 2024	SELL	$57.42 - $83.61 $788,146 - $1.15 Million	-13,726 Reduced 72.49%	5,208 $414,000
Q3 2023 Nov 06, 2023	BUY	$69.25 - $82.21 $1.05 Million - $1.25 Million	15,176 Added 403.83%	18,934 $1.32 Million
Q2 2023 Jul 27, 2023	SELL	$58.41 - $90.35 $5,023 - $7,770	-86 Reduced 2.24%	3,758 $270,000
Q1 2023 May 02, 2023	BUY	$58.39 - $75.0 $10,802 - $13,875	185 Added 5.06%	3,844 $237,000
Q4 2022 Feb 10, 2023	BUY	$39.94 - $79.72 $1,318 - $2,630	33 Added 0.91%	3,659 $282,000
Q4 2022 Feb 09, 2023	BUY	$39.94 - $79.72 $144,822 - $289,064	3,626 New	3,626 $279,000
Q3 2021 Nov 02, 2021	SELL	$19.91 - $68.26 $88,420 - $303,142	-4,441 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$50.63 - $73.5 $5,923 - $8,599	-117 Reduced 2.57%	4,441 $300,000
Q1 2021 May 04, 2021	SELL	$55.91 - $81.44 $142,067 - $206,939	-2,541 Reduced 35.79%	4,558 $258,000
Q4 2020 Feb 01, 2021	SELL	$66.31 - $86.52 $105,963 - $138,258	-1,598 Reduced 18.37%	7,099 $578,000
Q3 2020 Nov 09, 2020	BUY	$68.34 - $85.84 $63,419 - $79,659	928 Added 11.94%	8,697 $620,000
Q2 2020 Aug 07, 2020	SELL	$49.87 - $98.69 $171,602 - $339,592	-3,441 Reduced 30.7%	7,769 $639,000
Q1 2020 May 04, 2020	SELL	$41.2 - $101.31 $102,052 - $250,944	-2,477 Reduced 18.1%	11,210 $659,000
Q4 2019 Feb 06, 2020	BUY	$16.71 - $106.24 $4,411 - $28,047	264 Added 1.97%	13,687 $1.42 Million
Q4 2019 Feb 04, 2020	BUY	$16.71 - $106.24 $73,540 - $467,562	4,401 Added 48.78%	13,423 $1.17 Million
Q3 2019 Nov 12, 2019	BUY	$20.24 - $29.16 $182,605 - $263,081	9,022 New	9,022 $183,000

Others Institutions Holding AXSM

# of Institutions

324

Shares Held

37.7M

Call Options Held

797K

Put Options Held

747K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.18B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Axsome Therapeutics, Inc. Transaction History